• Citer

Structurally unique Na+/K+-ATPase antagonist UNBS1450: the first hemi-synthetic cardenolide with marked anti-tumor activity to enter clinical trials.

par Mijatovic, Tatjana ;Van Quaquebeke, Eric ;Van Vynckt, Frank;Weitman, Steve;Kiss, Robert
Référence American Association for Cancer Research Annual Meeting (100th: April: Denver - CO)
Publication Non publié, 2009

Poster de conférence

• Détails

Titre:	Structurally unique Na+/K+-ATPase antagonist UNBS1450: the first hemi-synthetic cardenolide with marked anti-tumor activity to enter clinical trials.
Auteur:	Mijatovic, Tatjana; Van Quaquebeke, Eric; Van Vynckt, Frank; Weitman, Steve; Kiss, Robert
Informations sur la publication:	American Association for Cancer Research Annual Meeting (100th: April: Denver - CO)
Statut de publication:	Non publié, 2009
Sujet CREF:	Sciences bio-médicales et agricoles
Note générale:	Abstract 2711
Langue:	Anglais